Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome

Reproductive BioMedicine Online

Volumn 8, Issue 6, 2004, Pages 649-656

  Yildiz, Bulent O ^a,b   Gedik, Olcay ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Glucose intolerance; Insulin resistance; Polycystic ovarian syndrome; Screening; Variability

Indexed keywords

GLUCOSE; INSULIN;

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL PRACTICE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; SCREENING; VALIDATION PROCESS;

EID: 2942541733     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)61645-8     Document Type: Article

References (71)

1. American Diabetes Association (ADA) Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20, 1183-1197.
2. American Diabetes Association (ADA) 1998 Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association. Diabetes Care 21, 310-314.
3. American Diabetes Association (ADA) 2002 Screening for diabetes. Diabetes Care 25, 21-24.
4. Belfiore F, Iannello S, Volpicelli G 1998 Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Molecular Genetics and Metabolism 63, 134-141.
5. Ben-Shlomo I 2002 The polycystic ovary syndrome: what does insulin resistance have to do with it? Reproductive BioMedicine Online 6, 36-42.
6. Bergman RN, Ider YZ, Bowden CR, Cobelli C 1979 Quantitative estimation of insulin sensitivity. American Journal of Physiology 236, E667-677.
7. Burghen GA, Givens JR, Kitabchi AE 1980 Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. Journal of Clinical Endocrinology and Metabolism 50, 113-116.
8. Carmina E 2004 Diagnosis of polycystic ovary syndrome: from NIH criteria to ESHRE-ASRM guidelines. Minerva Ginecologica 56, 1-6.
9. Carmina E, Koyama T, Chang L et al. 1992 Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome? American Journal of Obstetrics and Gynecology 167, 1807-1812.
10. Carmina E, Legro RS, Stamets K et al. 2003 Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Human Reproduction 18, 2289-2293.
11. Cederholm J, Wibell L 1990 Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Research and Clinical Practice 10, 167-175.
12. Chevenne D, Trivin F, Porquet D 1999 Insulin assays and reference values. Diabetes Metabolism 25, 459-476.
13. DECODE Study Group, the European Diabetes Epidemiology Group 2001 Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Archives of Internal Medicine 161, 397-405.
14. DECODE Study Group, the European Diabetes Epidemiology Group 2003 Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26, 688-696.
15. DeFronzo RA, Ferrannini E 1982 Influence of plasma glucose and insulin concentration on plasma glucose clearance in man. Diabetes 31, 683-688.
16. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. American Journal of Physiology 237, E214-223.
17. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews 18, 774-800.
18. Dunaif A, Segal KR, Futterweit W et al. 1989 Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38, 1165-1174.
19. Edelstein SL, Knowler WC, Bain RP et al. 1997 Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46, 701-710.
20. Ehrmann DA, Barnes RB, Rosenfield RL et al. 1999 Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141-146.
21. Ferrannini E, Mari A 1998 How to measure insulin sensitivity. Journal of Hypertension 16, 895-906.
22. Finegood DT, Hramiak IM, Dupre J 1990 A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. Journal of Clinical Endocrinology and Metabolism 70, 1538-1549.
23. Franks S, Roberts R, Hardy K 2003 Gonadotrophin regimens and oocyte quality in women with polycystic ovaries. Reproductive BioMedicine Online 6, 181-184.
24. Geisthövel F 2003 A comment on the European Society of Human Reproduction and Embryology/American Society for Reproductive Medicine consensus of the polycystic ovary syndrome. Reproductive BioMedicine Online 7, 602-605.
25. Genuth S, Alberti KG, Bennett P et al. 2003 Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160-3167.
26. Gutt M, Davis CL, Spitzer SB et al. 2000 Validation of the insulin sensitivity index (ISI(0, 120)): comparison with other measures. Diabetes Research and Clinical Practice 47, 177-184.
27. Hanefeld M, Temelkova-Kurktschiev T, Schaper F et al. 1999 Impaired fasting glucose is not a risk factor for atherosclerosis. Diabetic Medicine 16, 212-218.
28. Harano Y, Ohgaku S, Hidaka H et al. 1977 Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 45, 1124-1127.
29. Hollenbeck C, Reaven GM 1987 Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. Journal of Clinical Endocrinology and Metabolism 64, 1169-1173.
30. Homburg R 2002 What is polycystic ovarian syndrome? A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome. Human Reproduction 17, 2495-2499.
31. Jayagopal V, Kilpatrick ES, Holding S et al. 2002 The biological variation of insulin resistance in polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism 87, 1560-1562.
32. Kahn CR 1985 The molecular mechanism of insulin action. Annual Reviews of Medicine 36, 429-451.
33. Katz A, Nambi SS, Mather K et al. 2000 Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Journal of Clinical Endocrinology and Metabolism 85, 2402-2410.
34. Knowler WC, Barrett-Connor E, Fowler SE et al. 2002 Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine 346, 393-403.
35. Legro RS 2001 Diabetes prevalence and risk factors in polycystic ovary syndrome. Obstetrics and Gynecology Clinics of North America 28, 99-109.
36. Legro RS, Finegood D, Dunaif A 1998 A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 83, 2694-2698.
37. Legro RS, Kunselman AR, Dodson WC et al, 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology and Metabolism 84, 165-169.
38. Levine R, Haft DE 1970 Carbohydrate homeostasis. New England Journal of Medicine 283, 237-246.
39. Mari A 2002 Mathematical modeling in glucose metabolism and insulin secretion. Current Opinion in Clinical Nutrition and Metabolic Care 5, 495-501.
40. Mari A, Pacini G, Murphy E et al. 2001 A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24, 539-548.
41. Mather KJ, Hunt AE, Steinberg HO et al. 2001 Repeatability characteristics of simple indices of insulin resistance: implications for research applications. Journal of Clinical Endocrinology and Metabolism 86, 5457-5464.
42. Matsuda M, DeFronzo RA 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462-1470.
43. Matthews DR, Hosker JP, Rudenski AS et al. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
44. National Diabetes Data Group (NDDG) 1979 Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28, 1039-1057.
45. Norman RJ, Mahabeer S, Masters S 1995 Ethnic differences in insulin and glucose response to glucose between white and Indian women with polycystic ovary syndrome. Fertility and Sterility 63, 58-62.
46. Norman RJ, Masters L, Milner CR et al. 2001 Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Human Reproduction 16, 1995-1998.
47. Norman RJ, Davies MJ, Lord I et al. 2002 The role of lifestyle modification in polycystic ovary syndrome. Trends in Endocrinology and Metabolism 13, 251-257.
48. O'Rahilly S, Burnett MA, Smith RF et al. 1987 Haemolysis affects insulin but not C-peptide immunoassay. Diabetologia 30, 394-396.
49. Parra A, Ramirez A, Espinosa de los Monteros A 1994 Fasting glucose/insulin ratio. An index to differentiate normo from hyperinsulinemic women with polycystic ovary syndrome. Revista de Investigación Clínica 46, 363-368.
50. Quon MJ 2001 Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 86, 4615-4617.
51. Robbins DC, Andersen L, Bowsher R et al. 1996 Report of the American Diabetes Association's Task Force on standardization of the insulin assay. Diabetes 45, 242-256.
52. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19, 41-47.
53. Sapin R 2003 Insulin assays: previously known and new analytical features. Clinica y Laborarorio 49, 113-121.
54. Stadtmauer LA, Toma SK, Riehl RM et al. 2002 Impact of metformin therapy on ovarian stimulation and outcome in 'coasted patients' with polycystic ovary syndrome undergoing in-vitro fertilizitation. Reproductive BioMedicine Online 5, 112-116.
55. Stumvoll M, Mitrakou A, Pimenta W et al. 2000 Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295-301.
56. Taniguchi A, Nagasaka S, Fukushima M et al. 2000 Assessment of insulin sensitivity and insulin secretion from the oral glucose tolerance test in nonobese Japanese type 2 diabetic patients: comparison with minimal-model approach. Diabetes Care 23, 1439-1440.
57. Tominaga M, Eguchi H, Manaka H et al. 1999 Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22, 920-924.
58. Tsilchorozidou T, Overton C, Conway GS 2004 The pathophysiology of polycystic ovary syndrome. Clinical Endocrinology 60, 1-17.
59. Tuomilehto J, Lindstrom J, Eriksson JG et al. 2001 Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine 344, 1343-1350.
60. Turner RC, Holman RR, Matthews D et al. 1979 Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism 28, 1086-1096.
61. Unwin N, Shaw J, Zimmet P et al. 2002 Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabetic Medicine 19, 708-723.
62. Wallace TM, Matthews DR 2002 The assessment of insulin resistance in man. Diabetic Medicine 19, 527-534.
63. Weerakiet S, Srisombut C, Bunnag P et al. 2001 Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. International Journal of Gynaecology and Obstetrics 75, 177-184.
64. Wijeyaratne CN, Balen AH, Barth JH et al. 2002 Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) aniong Sotilh Asians and Caucasians: is there a difference? Clinical Endocrinology 57, 343-350.
65. World Health Organization (WHO) 1980 World Health Organization Expert Committee on Diabeies Mellitus Second Report. Technical Report Series 646. World Health Organization, Geneva, Switzerland.
66. World Health Organization (WHO) 1985 Diabetes Mellitus: report of a WHO study group. Technical Report Series No: 727. World Health Organization, Geneva.
67. World Health Organization (WHO) 1999 Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO consultation. Part 1. Diagnosis and classiflcation of diabetes mellitus. World Health Organization, Geneva.
68. Yang YJ, Youn JH, Bergman RN 1987 Modified protocols improve insulin sensitivity estimation using the minimal model. American Journal of Physiology 253, E595-602.
69. Yildiz BO, Haznedaroglu IC, Kirazli S et al. 2002 Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. Journal of Clininical Endocrinology and Metabolism 87, 3871-3875.
70. Yildiz BO, Chang W, Azziz R 2003 Polycystic ovary syndrome and ovulation induction. Minerva Ginecologica 55, 425-439.
71. Zawadzki JK, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome, pp. 377-84. In: Dunaif A, Haseltine F, Merriam GR (eds) Polycystic Ovary Syndrome Blackwell Scientific Publications, Boston, MA.